🚀 Your financial runway shouldn't run out before your innovation takes off. Medical innovators face a brutal reality: getting to First-in-Human trials in the US or Europe takes 6+ months and costs a fortune. By then, your funding is gone. There's a smarter path. This video explains The Innovation Runway—how…
🚀 First-in-Human Clinical Trials 40% Faster & 30% Lower Cost | MedTech & Biopharma Startups Struggling with endless delays and skyrocketing costs for your first-in-human studies? Discover the Latin American Advantage — a proven strategy that's transforming how innovative MedTech and biopharma companies bring life-saving breakthroughs to patients. 📊 KEY…
In this episode, we’re joined by Alfonso, CEO at Leon Research and Managing Board Member at AICROS, to dive into leadership, growth, and innovation in clinical research. With 14 years of experience in executive and managerial roles—including over a decade in clinical investigation—Alfonso brings a unique, multidisciplinary perspective shaped by…
In this episode of Global Trial Accelerators, we sit down with Justin Chickles, CEO and co-founder of Glycyx Therapeutics, a clinical-stage biotech company taking on a hidden threat to cancer immunotherapy success: opioids. With over two decades of leadership across therapeutics, diagnostics, and digital health — including roles at Johnson…
In this episode, we welcome Steven Collens, CEO of MATTER, one of the world’s leading healthcare incubators and innovation hubs. Under Steven’s leadership, MATTER has supported more than 1,000 healthcare startups, helping innovators move faster, collaborate more effectively, and significantly improve their chances of success. MATTER works at the intersection…
In this episode, we welcome Pablo Yarza, a bioinformatics specialist with more than 15 years of experience developing advanced databases for academic and industrial use. Pablo shares his professional journey, the challenges of data curation in R&D environments, and how data quality issues can lead to costly delays in research…
In this episode, we welcome Scott Stout, a leader focused on transforming access to clinical trials through innovative provider engagement models. Through HCP Recruitment, Scott and the team at MedVector are redefining how clinical trial sites connect with patients by unlocking access to larger, more diverse populations. MedVector enables trusted…
In this episode, we welcome Matteo Talotta, a professional whose global and multidisciplinary background spans banking, academia, government, start-ups, scale-ups, and multinational corporations. Having worked across Canada, Italy, the United States, Spain, and Romania, Matteo brings a unique, firsthand perspective on the diverse challenges and opportunities within healthcare systems around…
In today’s episode, we sit down with Sonal Pendharkar Kulkarni, Ph.D., Co-founder and CSO of Uvisa Health. With expertise spanning women’s health, the microbiome, digital health, and medical device innovation, Sonal is leading groundbreaking work that aims to transform how vaginal health is understood and managed worldwide. She shares her…
In this episode, we sit down with David Kraemer, Founder of a boutique investment bank and former Vice President at Merrill Lynch and Wilshire Consulting. With deep experience across investment banking, venture capital, biotech, AI, and emerging technologies, David shares insights on capital formation, innovation, and navigating global markets. Tune…
In this episode, we sit down with Dr. Joseph M. Palumbo, a physician-scientist, mentor, and therapeutics developer with over three decades of leadership in psychiatry, neurology, and neurodegenerative research. Dr. Palumbo has held senior roles as Global Head of Psychiatry at Johnson & Johnson, Vice President & Fellow at Mitsubishi…
In this episode, we sit down with Dr. Joseph M. Palumbo, a physician-scientist, mentor, and therapeutics developer with over three decades of leadership in psychiatry, neurology, and neurodegenerative research. Dr. Palumbo has held senior roles as Global Head of Psychiatry at Johnson & Johnson, Vice President & Fellow at Mitsubishi…
In this episode, we sit down with Nicholas Kadysh, CEO of PharmAla Biotech, the company pioneering GMP MDMA production and recognized as the top-performing stock on the Canadian capital markets in 2023 by The Market Herald. As Chair of Psychedelics Canada, Nicholas has played a pivotal role in strengthening legal…
Carolina is a senior biotech executive with over 25 years of experience in the biopharmaceutical industry. She is the Founder & Principal of Bio Strategy Advisors, a strategic consulting firm specializing in start-up formation, corporate strategy, strategic partnerships, and global expansion. She currently serves on the boards of Syte.bio, Bonds…
In this episode, we welcome Dr. Jason Hurt, a clinician-scientist and entrepreneur with deep expertise in radiopharmaceutical development, clinical trial strategy, and oncology drug development. Dr. Hurt is the founder of Theragnostic Insights, a consulting and strategic advisory firm launched in March 2025 that is dedicated to advancing theranostic solutions…
In this episode, we talk with Dr. Martin R. Schiller, a renowned scientist, professor at UNLV, and founder of Heligenics Inc. Dr. Schiller shares his journey from academia to biotech entrepreneurship, his work leading the Nevada Institute of Personalized Medicine, and how his breakthrough technology, the GigaAssay, is transforming drug…
In this episode, we welcome Ross O. Youngs, Founder and CEO with over 35 years of experience inventing products, technologies, and processes across a wide range of industries. Holder of more than 75 patents worldwide, Ross is driven by innovation that is better, faster, and more cost-effective. He has been…
In this episode, we sit down with Gianluca Fontana, CEO and Co-Founder of Prova Health, the London-based advisory firm accelerating digital-health and life-sciences innovation through clinical and economic evidence. With a career spanning McKinsey, Imperial College London, and leadership of billion-pound research programs like the NHS Digital Academy and the…
In this episode of Global Trial Accelerators, we sit down with Justin Chickles, CEO and co-founder of Glycyx Therapeutics, a clinical-stage biotech company taking on a hidden threat to cancer immunotherapy success: opioids. With over two decades of leadership across therapeutics, diagnostics, and digital health — including roles at Johnson…
Today’s guest is Dr. Sarfaraz K. Niazi, a globally recognized biopharmaceutical scientist, regulatory advisor, prolific author, and inventor. Dr. Niazi works closely with regulatory authorities to streamline guidelines and help companies comply in bringing biotherapeutic products to market—including biosimilars, gene therapies, mRNA vaccines, and advanced protein delivery systems. He has…
In this episode, we sit down with Steve Duddy, a powerhouse executive with over 20 years of experience leading high-impact transformations across startups and Fortune 500 companies like 3M and Johnson & Johnson. Steve shares his unique approach to uncovering hidden opportunities, turning ambiguity into actionable strategy, and executing bold…
Andrés Herrero is a dynamic entrepreneur with over 25 years of experience in the healthcare and medical device industries. Andrés has founded his company “i 2 medi” ten years ago with the purpose to gain market access for innovative medical device companies in Latin America. Today the company has evolved…
🎙️ New Episode of LATAM Medtech Leaders with Javier Handal 🎙️ In this episode, we have the pleasure of speaking with Javier Handal, a Medical Doctor with extensive experience in clinical research and pharmaceutical industry operations. As the leader of MRx Solution, a Site Management Organization (SMO), Javier is driving…
Today, we have the privilege of speaking with Andrew, a distinguished leader with over 15 years of international experience in marketing, commercial excellence, and business strategy. Throughout his career, he has led large teams at top pharmaceutical and medical device companies, including Novartis, Terumo, and Penumbra Inc. Andrew is a…